Vor Biopharma Inc. · NASDAQ:VOR
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Vor Biopharma Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Vor Biopharma Inc., 5,676,370 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 5,676,370
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 5,676,370 |
| VHCP Co-Investment Holdings III, LLC | 9.90% | 5,676,370 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.90% | 5,676,370 |
| VHCP Management III, LLC | 9.90% | 5,676,370 |
| VHCP Management EG, LLC | 9.90% | 5,676,370 |
| Nimish Shah | 9.90% | 5,676,370 |
| Bong Y. Koh | 9.90% | 5,676,370 |
Source
Related
- Vor Biopharma Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Vor Biopharma Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 17, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 25, 2025
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2026